We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Sunrun (RUN) Q3 Earnings Miss Estimates, Revenues Up Y/Y
Read MoreHide Full Article
Sunrun Inc. (RUN - Free Report) reported third-quarter 2019 adjusted earnings of 23 cents per share, which missed the Zacks Consensus Estimate of 27 cents by 14.8%. However, the bottom line rose from a loss of 2 cents per share in the prior- year quarter.
Revenues
Sunrun’s revenues of $215.5 million in the quarter surpassed the Zacks Consensus Estimate of $207.5 million by 3.9%. Revenues also rose 5% from the year-ago quarter’s $204.9 million.
Operational Highlights
Total operating expenses were $275.9 million in the third quarter, up 20.7% year over year. Operating expenses in the reported quarter grew on escalated costs of customer agreements and incentives, high costs of solar energy systems and product sales, increased sales and marketing expenses, higher general and administrative costs, and elevated research and development expenses.
Interest expenses were $43.9 million, up approximately 27.3% on a year-over-year basis.
Total cost of revenues was $159.4 million, increasing 14% year over year.
Key Highlights
In the reported quarter, Megawatt (MW) deployed grew 7% to 107 MW from 100 MW in the third quarter of 2018.
Creation cost per watt was $3.28 in the third quarter of 2019 compared with $3.34 in the year-ago quarter. Net Present Value (NPV) created in the quarter was $79 million, reflecting an 8.1% year-over-year decline from $86 million in the third quarter of 2018.
Sunrun’s net earning assets as of Sep 30, 2019, were $1.4 billion, up $48 million or 3% from the prior-year quarter.
The company’s customer base expanded 24% year over year to 271,000.
Sunrun had $324.7 million of cash, as of Sep 30, 2019, up from $226.6 million at the end of 2018.
Net cash outflow from operating activities was $106.1 million at the end of the third quarter compared with $40.7 million used for operating activities in the year-ago quarter.
Total recourse and non-recourse debt, net of current portion, was $2,015.9 million at the end of third-quarter 2019 compared with $1,713.4 million as of Dec 31, 2018.
Q4 Guidance
For the fourth quarter of 2019, Sunrun expects deployments of 115-118 MW.
SunPower Corp. reported adjusted earnings of 22 cents per share in third-quarter 2019. The Zacks Consensus Estimate was a loss of a penny. The company had incurred a loss of 29 cents per share in the year-ago quarter.
Enphase Energy, Inc. (ENPH - Free Report) reported third-quarter 2019 adjusted earnings of 30 cents per share, which surpassed the Zacks Consensus Estimate of 25 cents by 20%. The bottom line also improved a massive 650% from 4 cents reported in the prior-year quarter.
First Solar Inc. (FSLR - Free Report) reported third-quarter 2019 adjusted earnings of 29 cents per share, missing the Zacks Consensus Estimate of $1.06 by 72.6%. The reported number, however, grew from the prior-year quarter’s loss per share of 18 cents.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Sunrun (RUN) Q3 Earnings Miss Estimates, Revenues Up Y/Y
Sunrun Inc. (RUN - Free Report) reported third-quarter 2019 adjusted earnings of 23 cents per share, which missed the Zacks Consensus Estimate of 27 cents by 14.8%. However, the bottom line rose from a loss of 2 cents per share in the prior- year quarter.
Revenues
Sunrun’s revenues of $215.5 million in the quarter surpassed the Zacks Consensus Estimate of $207.5 million by 3.9%. Revenues also rose 5% from the year-ago quarter’s $204.9 million.
Operational Highlights
Total operating expenses were $275.9 million in the third quarter, up 20.7% year over year. Operating expenses in the reported quarter grew on escalated costs of customer agreements and incentives, high costs of solar energy systems and product sales, increased sales and marketing expenses, higher general and administrative costs, and elevated research
and development expenses.
Interest expenses were $43.9 million, up approximately 27.3% on a year-over-year basis.
Total cost of revenues was $159.4 million, increasing 14% year over year.
Key Highlights
In the reported quarter, Megawatt (MW) deployed grew 7% to 107 MW from 100 MW in the third quarter of 2018.
Creation cost per watt was $3.28 in the third quarter of 2019 compared with $3.34 in the year-ago quarter. Net Present Value (NPV) created in the quarter was $79 million, reflecting an 8.1% year-over-year decline from $86 million in the third quarter of 2018.
Sunrun’s net earning assets as of Sep 30, 2019, were $1.4 billion, up $48 million or 3% from the prior-year quarter.
The company’s customer base expanded 24% year over year to 271,000.
Sunrun Inc. Price, Consensus and EPS Surprise
Sunrun Inc. price-consensus-eps-surprise-chart | Sunrun Inc. Quote
Financial Performance
Sunrun had $324.7 million of cash, as of Sep 30, 2019, up from $226.6 million at the end of 2018.
Net cash outflow from operating activities was $106.1 million at the end of the third quarter compared with $40.7 million used for operating activities in the year-ago quarter.
Total recourse and non-recourse debt, net of current portion, was $2,015.9 million at the end of third-quarter 2019 compared with $1,713.4 million as of Dec 31, 2018.
Q4 Guidance
For the fourth quarter of 2019, Sunrun expects deployments of 115-118 MW.
Zacks Rank
Sunrun currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Recent Solar Releases
SunPower Corp. reported adjusted earnings of 22 cents per share in third-quarter 2019. The Zacks Consensus Estimate was a loss of a penny. The company had incurred a loss of 29 cents per share in the year-ago quarter.
Enphase Energy, Inc. (ENPH - Free Report) reported third-quarter 2019 adjusted earnings of 30 cents per share, which surpassed the Zacks Consensus Estimate of 25 cents by 20%. The bottom line also improved a massive 650% from 4 cents reported in the prior-year quarter.
First Solar Inc. (FSLR - Free Report) reported third-quarter 2019 adjusted earnings of 29 cents per share, missing the Zacks Consensus Estimate of $1.06 by 72.6%. The reported number, however, grew from the prior-year quarter’s loss per share of 18 cents.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>